CYTOSORBENTS CORPORATION Accrued Royalties, Current
CYTOSORBENTS CORPORATION (CTSO) had Accrued Royalties, Current of $558.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Royalties, Current $558.00K.
- 2026-03-31: Accrued Royalties, Current $268.00K.
- 2025-12-31: Accrued Royalties, Current $271.00K.
- 2025-09-30: Accrued Royalties, Current $282.00K.
| Period end | Accrued Royalties, Current | Accrued Royalties, Current as first filed |
|---|---|---|
| 2026-06-30 | $558.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $268.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $271.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $282.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $287.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $257.88K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $275.00K 10-K · filed 2026-03-30 | $275.41K 10-Q · filed 2025-05-14 |
| 2023-12-31 | $513.34K 10-K · filed 2024-03-15 | |
| 2022-12-31 | $592.40K 10-K · filed 2024-03-15 | |
| 2021-12-31 | $769.26K 10-K · filed 2023-03-09 | |
| 2020-12-31 | $916.70K 10-K · filed 2022-03-10 | |
| 2019-12-31 | $525.00K 10-K · filed 2021-03-09 | |
| 2018-12-31 | $433.59K 10-K · filed 2020-03-05 | |
| 2017-12-31 | $334.33K 10-K · filed 2019-03-07 | |
| 2016-12-31 | $183.05K 10-K · filed 2018-03-08 | |
| 2015-12-31 | $102.59K 10-K · filed 2017-03-03 | |
| 2014-12-31 | $45.20K 10-K · filed 2016-03-09 | |
| 2013-12-31 | $15.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |